Who is the actress in the Kesimpta commercial?
Jamie-Lynn Sigler, best known for her role as Meadow Soprano on the Sopranos (HBO), is the actress who appears in the 2023/2024 Kesimpta commercial. Sigler also has relapsing Multiple Sclerosis (MS).
Kami Dimitrova is the actress who appears in the Kesimpta ‘Drama’ commercial. She is an actor and comedian based in Los Angeles. The voice you hear in the commercial, however, doesn’t belong to Dimitrova. The voice over is provided by Jen Jacob, an actress known for her roles in the movies Begin Again (2013) and Top Five (2014), and the TV series Girls (2012),
Kami Dimitrova - the national face of the Kesimpta brand - also appears in another Kesimpta commercial, but a different, male-sounding actor provides the voice used in that commercial.
Kesimpta (ofatumumab) is a prescription medication. It is administered by injection under the skin (subcutaneous injection) and is used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
References
- Commercial Archivist. Kesimpta Commercial 2021. https://www.youtube.com/watch?v=jlWrJhz7Ic0
- Kesimpta Package Insert. https://www.novartis.com/us-en/sites/novartis_us/files/kesimpta.pdf
- Jamie-Lynn Sigler. IMDb. https://www.imdb.com/name/nm0797464/
Read next
What are monoclonal antibodies?
Monoclonal antibodies (mAbs) are man-made proteins that mimic the natural antibodies produced by our immune systems. Monoclonal antibodies can be formulated into medicines to treat various types of illnesses, such as cancer, rheumatoid arthritis or psoriasis. Continue reading
Is Kesimpta better than Ocrevus?
In patients with relapsing forms of multiple sclerosis, Kesimpta (ofatumumab) is thought to be more effective than Ocrevus (ocrelizumab) in some ways, but no clinical trials have directly compared the two drugs
Ocrevus is the only one of the two drugs approved to treat primary progressive multiple sclerosis Continue reading
What are 8 key Kesimpta side effects to watch out for?
Kesimpta (ofatumumab) is an FDA-approved anti-CD20 monoclonal antibody used to treat relapsing forms of multiple sclerosis (MS) in adults. Like all medications, there are several side effects you should watch out for and know how to manage. Continue reading
Related medical questions
- How long can Kesimpta be out of the fridge?
- How long does it take for Kesimpta to work?
- Where and how is Kesimpta injected?
- How is Arzerra administered and how long to work?
- How long can you live with multiple sclerosis?
- What are the early warning signs of Multiple Sclerosis?
- How do you test for multiple sclerosis?
- What are the early signs of multiple sclerosis?
- Prednisone: What are 12 Things You Should Know?
- Prednisone vs Prednisolone - What's the difference?
- What are the new drugs used for multiple sclerosis (MS)?
- How much does Ocrevus cost?
- Briumvi vs Ocrevus: How do they compare?
- What are 8 key Mavenclad side effects to watch out for?
- How long does it take Ocrevus to work?
- Is Tecfidera an immunosuppressant?
- How do Vumerity and Tecfidera compare for multiple sclerosis (MS)?
- Can I stop taking Tecfidera? What happens if I do?
- Ocrevus side effects: What are 5 key side effects to watch for?
- How long does an Ocrevus infusion take?
- Is Ocrevus a form of chemotherapy?
- What causes flushing with Tecfidera?
- Can you drink alcohol while taking Tecfidera?
- Where and how should Copaxone be injected?
- Does Tysabri suppress the immune system?
- How effective is Mavenclad for MS?
- How quickly does Mavenclad work?
- How does Ocrevus work for MS?
- What happens when you stop taking Gilenya?
Drug information
- Kesimpta Information for Consumers
- Kesimpta prescribing info & package insert (for Health Professionals)
- Side Effects of Kesimpta (detailed)
- Kesimpta user reviews (74)
Related support groups
- Kesimpta (7 questions, 3 members)
- Multiple Sclerosis (98 questions, 557 members)